BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26274053)

  • 1. Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells.
    Trendowski M; Christen TD; Zoino JN; Acquafondata C; Fondy TP
    J Vis Exp; 2015 Jul; (101):e53060. PubMed ID: 26274053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle growth control parameters to induce sensitivity to low frequency ultrasound.
    Trendowski M; Wong V; Zoino JN; Christen TD; Gadeberg L; Sansky M; Fondy TP
    Cancer Lett; 2015 May; 360(2):160-70. PubMed ID: 25667120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells.
    Trendowski M; Yu G; Wong V; Acquafondata C; Christen T; Fondy TP
    Anticancer Res; 2014 May; 34(5):2195-202. PubMed ID: 24778021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of ultrasound in drug delivery systems: emphasis on experimental methodology and mechanisms.
    Feril LB; Tachibana K
    Int J Hyperthermia; 2012; 28(4):282-9. PubMed ID: 22621730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of sonodynamic therapy.
    Trendowski M
    Cancer Metastasis Rev; 2014 Mar; 33(1):143-60. PubMed ID: 24346159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protoporphyrin IX-mediated sonodynamic action induces apoptosis of K562 cells.
    Su X; Li Y; Wang P; Wang X; Liu Q
    Ultrasonics; 2014 Jan; 54(1):275-84. PubMed ID: 23978616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.
    Trendowski M
    Chemother Res Pract; 2015; 2015():316015. PubMed ID: 26380110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products in the discovery of novel sonosensitizers.
    Pang X; Xu C; Jiang Y; Xiao Q; Leung AW
    Pharmacol Ther; 2016 Jun; 162():144-51. PubMed ID: 26706240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between sonodynamic effect with protoporphyrin IX and hematoporphyrin on sarcoma 180.
    Liu Q; Wang X; Wang P; Xiao L; Hao Q
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):671-80. PubMed ID: 17219011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparision between sonodynamic effects with protoporphyrin IX and hematoporphyrin on the cytoskeleton of Ehrlich ascites carcinoma cells.
    Wang P; Wang X; Liu Q; Zhao X; Cao B; Zhao P
    Cancer Biother Radiopharm; 2010 Feb; 25(1):55-64. PubMed ID: 20187797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonodynamic therapy: A potential treatment for atherosclerosis.
    Geng C; Zhang Y; Hidru TH; Zhi L; Tao M; Zou L; Chen C; Li H; Liu Y
    Life Sci; 2018 Aug; 207():304-313. PubMed ID: 29940244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloporphyrin-Encapsulated Biodegradable Nanosystems for Highly Efficient Magnetic Resonance Imaging-Guided Sonodynamic Cancer Therapy.
    Huang P; Qian X; Chen Y; Yu L; Lin H; Wang L; Zhu Y; Shi J
    J Am Chem Soc; 2017 Jan; 139(3):1275-1284. PubMed ID: 28024395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents.
    Trendowski M; Wong V; Yu G; Fondy TP
    Anticancer Res; 2015 Jan; 35(1):65-76. PubMed ID: 25550536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound dose fractionation in sonodynamic therapy.
    Barati AH; Mokhtari-Dizaji M
    Ultrasound Med Biol; 2010 Jun; 36(6):880-7. PubMed ID: 20510185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model.
    Tserkovsky DA; Alexandrova EN; Chalau VN; Istomin YP
    Exp Oncol; 2012 Dec; 34(4):332-5. PubMed ID: 23302991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects of low intensity ultrasound: the mechanism involved, and its implications on therapy and on biosafety of ultrasound.
    Feril LB; Kondo T
    J Radiat Res; 2004 Dec; 45(4):479-89. PubMed ID: 15635256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonodynamic therapy--a review of the synergistic effects of drugs and ultrasound.
    Rosenthal I; Sostaric JZ; Riesz P
    Ultrason Sonochem; 2004 Sep; 11(6):349-63. PubMed ID: 15302020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound and cisplatin combined treatment of human melanoma cells A375--the study of sonodynamic therapy.
    Bernard V; Mornstein V; Škorpíková J; Jaroš J
    Ultrasound Med Biol; 2012 Jul; 38(7):1205-11. PubMed ID: 22502893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonodynamic Therapy Based on Combined Use of Low Dose Administration of Epirubicin-Incorporating Drug Delivery System and Focused Ultrasound.
    Maeda M; Muragaki Y; Okamoto J; Yoshizawa S; Abe N; Nakamoto H; Ishii H; Kawabata K; Umemura S; Nishiyama N; Kataoka K; Iseki H
    Ultrasound Med Biol; 2017 Oct; 43(10):2295-2301. PubMed ID: 28705555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induction of human myeloid leukemic cells by ultrasound exposure.
    Ashush H; Rozenszajn LA; Blass M; Barda-Saad M; Azimov D; Radnay J; Zipori D; Rosenschein U
    Cancer Res; 2000 Feb; 60(4):1014-20. PubMed ID: 10706118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.